Do you have to communicate with people who make you want to pull your hair out (for those of us who still have hair)?
You communicate very clearly and they just don't "get" it - its like they are not even hearing you. It can be so frustrating trying to get your message across.
And then there are the people that talk too much without saying anything -they seem to talk just to hear themselves talk -it's so annoying.
Or those that don't communicate at all -are you supposed to read their minds -its exhausting trying to get anything substantive out of them.
Employee conflict costs organizations money, morale, and productivity. A rise in absenteeism and turnover is a likely sign that an organization is suffering from unresolved conflict.
In this webinar, you will learn how to handle conflicts caused by the tasks of the job and relationships with coworkers. You will learn how to evaluate the seriousness of the conflict and how to appropriately intervene. In addition, the role of emotional intelligence, confronting employees in conflict and dealing with common issues of conflict at all levels of the organization will be considered.
Make sure you are up to date on important payroll compliance issues. The webinar will discuss 2019 limits, the effects of the current legal case against the FLSA overtime changes; a look at unemployment issues for 2019.
We'll also look at FUTA Credit Reduction states for 2018 returns. Changes to state minimum wages, tip credit and new players in the Paid Family Leave area will be addressed. A look at any effects of the government shutdown will also be included.
The pros and cons of the 2 most widely used sampling plans (ANSI Z1.4, and Squeglia's C=0) are examined in detail, focusing especially on the weaknesses of such plans in regards to meeting regulatory requirements. Real-world examples are provided for how using such sampling plans leads to production of non-conforming product.
The advantages of "confidence/reliability" calculations are explained. Such calculations are demonstrated for Attribute data (pass/fail, yes/no data) as well as for variables data (i.e., measurements). If variables data is "Normally distributed" the calculations are extremely simple. The webinar explains how to handle "non-Normal" data, and provides the methods, formulas, and tools to handle non-normality.
The NACHA Operating Rules and Guidelines require that all participating depository financial institutions, third-party senders and third-party service providers that provide ACH services conduct an annual ACH audit to be performed by December 31 of each year (ACH Rules, Article 1).
With the requirement that each participant conducts an annual ACH audit, this helps to ensure that electronic payments work safely and efficiently for all users.
Why should you Attend: Due to a recently approved amendment to the NACHA Operating Rules, Appendix 8 has been removed from the Rules (Appendix 8 was the "guide" or checklist while completing the annual ACH Audit).
The ODFI is responsible for the registration process for any Third-Party Senders and nested TPS; registration is also necessary even if there is no TPS relationship.
Why should you Attend:
The registration process will promote consistent customer due diligence among all ODFIs, and serve as a tool to support NACHA's continuing efforts to maintain ACH Network quality.
Fishbone Diagramming is an analytical approach used to identify and solve problems. Analysis is presented in the Seven Basic Tools of Quality in addition to advanced methods used to increase organizations effectiveness, efficiency and reliability.
Specific areas presented:
Look for Evidence
The Post-it Exercise
Fish Bone Diagramming
Process Reliability Modeling
Critical Path Analysis
Value Stream Mapping
Failure Mode Effects Analysis
Early clinical trials are conducted to establish initial safety of a drug. The studies are generally in small number of healthy subjects and use lower doses of the drug product. Therefore, only small amounts of investigational material are required. In order to not undertake substantial costs and to reduce regulatory burden during these early stages, the FDA has established guidelines to allow early stage investigational products to be manufactured under less stringent GMPs.
Gaps, incorrect or incomplete implementation of safety functionality can delay or make the certification/approval of medical products impossible. Most activities cannot be retroactively performed since they are closely linked into the development lifecycle. Diligent, complete and correct implementation of risk management from the start of product development is therefore imperative. This course will introduce all necessary steps to design, implement and test critical medical devices in a regulatory compliant environment. This course will additionally address the software risk management and the resulting interfaces to device level risk management.
To comprehensively summarize all risk related activities and to demonstrate the safe properties
Why should you attend:
Statistics is a useful decision making tool in the clinical research arena. When working in a field where a p-value can determine the next steps on development of a drug or procedure, it is imperative that decision makers understand the theory and application of statistics.
Many statistical softwares are now available to professionals. However, these softwares were developed for statisticians and can often be daunting to non-statisticians. How do you know if you are pressing the right key, let alone performing the best test?
More Information Click Here: https://www.globalcompliancepanel.com/seminar/biostatistics-for-the-non-statistician-901936SEMINAR/?SEO
Learn the tips and tricks of visualizing Excel Data with Smart Art presentations and charts. Register today for the webinar. Price:$150.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 email@example.com Event link - https://www.onlinecompliancepanel.com/webinar/Visualizing-Excel-Data-with-Smart-Art-Presentations-and-Charts-505000/JANUARY-2019-ES-TRAININGREGISTRY
NIR is more complex than typical spectroscopic methods. This webinar will compare and contrast NIRS with “commonly used” spectrometers, now in use and more familiar to analysts.
Why should you Attend:
These can be hand-held, lab-based, or installed in process lines This webinar will explain the manner in which NIR works, the equipment available, and the applications where it may best be used.
After this webinar, you will be able to evaluate which type of NIR would be best for your application
This webinar provides a fundamental level appreciation of human factors and how it has been implemented within the engineering discipline to improve design and operation to support system goals.
Why should you Attend:
Understand the definition and scope of human factors
Recognize the benefits of user centred design
Identify opportunities where HF may improve current processes and designs
Discuss the regulatory environment in several jurisdictions
FDA steadily expands the scope and restrictions for promotion of products under its jurisdiction. Whatever and where ever to want to talk about your product, just assume your talking to FDA.
Trolling for off-label information in social media, scrutiny of educational material under "safe harbor" and apparent conflicts of interest at a public event create a sink hole for firms even though it may seem innocent in your eyes.
FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in many companies. One major failing is lack of sufficient or targeted risk-based company-wide V&V planning. Starting with a Master Validation Plan, evaluating its elements against ISO 14971 hazard analysis / risk management, allows development of meaningful product validations. The roles of different V&V protocols.
In this webinar speaker will explain How to write or record information in a compliant way (includes text, numbers, electronic signatures etc), In a pharmaceutical or medical device environment documentation needs to meet certain requirements to ensure product quality and product safety.
Statistical Methods are typically used to ensure that product performance, quality, and reliability requirements are met during the Design Validation phase of product development. This webinar discusses common elements of sample size determination and several specific sample size applications for various design validation activities including Reliability Demonstration/Estimation, Acceptance Sampling, and Hypothesis Testing.
This Project management training will provide you with a solid foundation for managing that first project or to simply sharpen existing project management skills, It is not just important to learn about project management - project management has its own body of knowledge, Also The webinar is designed to build a working understanding of the subject and for a quick start-up for those unanticipated project management assignments.
The logistics industry is huge, worldwide and critical to our global economy. The industry consists of transportation, warehousing, logistics and technology companies that move goods (physical assets) from producers to consumers.
The industry has grown rapidly in size and sophistication as supply chains became bigger and more demanding. Block chain is one of the technologies that may provide the next advancement in connectivity, speed, transparency, security, productivity and cost savings for the logistics industry.
Human error is known to be the major cause of quality and production losses in many industries. Although it is unlikely that human error will ever be totally eliminated, many human performance problems can be prevented. Human errors start at the design stage. From procedures, training, and workplace environment many variables that affect human behavior CAN be manipulated reducing the likelihood of these occurrences.
To work with these challenges it is really important to understand human behavior and the psychology of error as well as understand exactly where the systems weaknesses are, so they can be improved and/or fixed. This course offers practical approaches and models to address human performance issues in GMP related environments by using a specific methodology to correct, prevent and avoid re-occurrence of these issues.